United Kingdom

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

23 Aug 2019
Change (% chg)

$0.12 (+0.58%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Munoz, Alain 

Dr. Alain Munoz, Ph.D. has been Independent Member of the Board of Directors at Zealand Pharma A/S since 2007. He served as Director of the Company from 2005 until 2006 when he resigned. Alain Munoz has over 20 years of experience in the pharmaceutical industry at senior management level. Within the Sanofi Group he served as SVP for International development and in Fournier Laboratories as SVP for the Pharmaceutical division. He is Independant Board member of Valneva SEHybrigenics, , Auris medical and Oxthera, as well as adviser to Kurma Biofund. Alain Munoz holds an MD in Cardiology and Anaesthesiology from the Hospital Pitie-Salpetriere, Paris. He has numerous publications and has been a member of the scientific committee of the French Drug Agency (ANSM).

Basic Compensation

Total Annual Compensation, DKK 350,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 350,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --